Charles River Laboratories International (CRL) Market Cap 2000–2025
As of December 12, 2025, Charles River Laboratories International had a market cap of $9.500 billion, which decreased by 0.72% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.
Data updated: Dec 12, 2025, 4:00 PM ET
Charles River Laboratories International Inc. (CRL)
🌍 United States📈 NYSE🏭 Health Care🏢 Life Sciences Tools & Services
Note: Each point on the chart represents the market capitalization at the end of the trading day. Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.
📈 Charles River Laboratories International Market Cap History by Year and Month
Charles River Laboratories International Market Cap History by Year and Month
Year / Month
Market Cap
% Change
2025
$9.500B
▲ 0.64%
$9.500B
▲ 8.36%
$8.767B
▼ 1.07%
$8.862B
▲ 15.09%
$7.700B
▼ 4.19%
$8.037B
▼ 3.54%
$8.332B
▲ 11.81%
$7.452B
▲ 11.86%
$6.662B
▲ 14.35%
$5.826B
▼ 21.20%
$7.393B
▼ 12.55%
$8.454B
▲ 0.33%
$8.426B
▼ 10.74%
2024
$9.440B
▼ 22.16%
$9.440B
▼ 7.27%
$10.180B
▲ 11.46%
$9.133B
▼ 9.31%
$10.071B
▼ 1.36%
$10.210B
▼ 18.99%
$12.603B
▲ 18.44%
$10.641B
▼ 0.89%
$10.737B
▼ 8.98%
$11.796B
▼ 15.48%
$13.957B
▲ 6.93%
$13.053B
▲ 17.53%
$11.106B
▼ 8.42%
2023
$12.127B
▲ 9.38%
$12.127B
▲ 19.95%
$10.110B
▲ 17.05%
$8.637B
▼ 14.04%
$10.048B
▼ 5.24%
$10.604B
▼ 1.29%
$10.743B
▼ 0.17%
$10.761B
▲ 8.73%
$9.897B
▲ 1.72%
$9.730B
▼ 5.80%
$10.329B
▼ 7.64%
$11.184B
▼ 9.83%
$12.403B
▲ 11.87%
2022
$11.087B
▼ 41.71%
$11.087B
▼ 4.67%
$11.630B
▲ 7.70%
$10.799B
▲ 7.85%
$10.013B
▼ 4.08%
$10.439B
▼ 18.07%
$12.742B
▲ 17.08%
$10.883B
▼ 8.48%
$11.891B
▼ 3.08%
$12.269B
▼ 14.95%
$14.426B
▼ 1.87%
$14.701B
▼ 11.71%
$16.650B
▼ 12.46%
2021
$19.020B
▲ 52.94%
$19.020B
▲ 3.02%
$18.462B
▼ 18.45%
$22.640B
▲ 8.73%
$20.823B
▼ 6.92%
$22.371B
▲ 9.08%
$20.509B
▲ 10.03%
$18.640B
▲ 9.75%
$16.984B
▲ 1.66%
$16.706B
▲ 14.78%
$14.555B
▲ 2.18%
$14.244B
▲ 10.45%
$12.896B
▲ 3.70%
2020
$12.436B
▲ 66.35%
$12.436B
▲ 6.61%
$11.665B
▲ 2.99%
$11.326B
▲ 0.55%
$11.264B
▲ 3.56%
$10.877B
▲ 10.02%
$9.886B
▲ 14.18%
$8.658B
▼ 2.62%
$8.891B
▲ 24.18%
$7.160B
▲ 14.63%
$6.246B
▼ 18.00%
$7.617B
▲ 0.65%
$7.568B
▲ 1.23%
2019
$7.476B
▲ 37.02%
$7.476B
▲ 5.38%
$7.094B
▲ 11.75%
$6.348B
▼ 1.81%
$6.465B
▲ 0.95%
$6.404B
▼ 2.48%
$6.567B
▼ 5.07%
$6.918B
▲ 13.11%
$6.116B
▼ 10.69%
$6.848B
▼ 3.26%
$7.079B
▲ 3.24%
$6.857B
▲ 15.42%
$5.941B
▲ 8.89%
2018
$5.456B
▲ 5.25%
$5.456B
▼ 15.88%
$6.486B
▲ 10.68%
$5.860B
▼ 9.32%
$6.462B
▲ 8.93%
$5.932B
▼ 0.64%
$5.970B
▲ 11.01%
$5.378B
▲ 4.41%
$5.151B
▲ 3.19%
$4.992B
▼ 2.46%
$5.118B
▲ 1.21%
$5.057B
▲ 1.12%
$5.001B
▼ 3.53%
2017
$5.184B
▲ 43.76%
$5.184B
▲ 5.05%
$4.935B
▼ 10.39%
$5.507B
▲ 7.12%
$5.141B
▼ 0.71%
$5.178B
▲ 10.81%
$4.673B
▼ 3.03%
$4.819B
▲ 9.90%
$4.385B
▲ 2.62%
$4.273B
▼ 0.23%
$4.283B
▲ 3.96%
$4.120B
▲ 7.66%
$3.827B
▲ 6.13%
2016
$3.606B
▼ 3.94%
$3.606B
▲ 7.16%
$3.365B
▼ 6.29%
$3.591B
▼ 8.95%
$3.944B
▲ 0.23%
$3.935B
▼ 5.36%
$4.158B
▲ 6.67%
$3.898B
▼ 3.85%
$4.054B
▲ 8.40%
$3.740B
▲ 4.53%
$3.578B
▲ 4.28%
$3.431B
▼ 1.07%
$3.468B
▼ 7.62%
2015
$3.754B
▲ 24.63%
$3.754B
▲ 5.15%
$3.570B
▲ 17.40%
$3.041B
▲ 2.70%
$2.961B
▼ 8.13%
$3.223B
▼ 11.24%
$3.631B
▲ 10.20%
$3.295B
▼ 3.82%
$3.426B
▲ 4.61%
$3.275B
▼ 12.78%
$3.755B
▲ 3.47%
$3.629B
▲ 10.57%
$3.282B
▲ 8.96%
2014
$3.012B
▲ 19.43%
$3.012B
▼ 0.86%
$3.038B
▲ 2.53%
$2.963B
▲ 6.05%
$2.794B
▲ 1.27%
$2.759B
▲ 9.01%
$2.531B
▲ 0.84%
$2.510B
▼ 3.16%
$2.592B
▼ 0.23%
$2.598B
▼ 10.97%
$2.918B
▲ 3.07%
$2.831B
▲ 5.32%
$2.688B
▲ 6.58%
2013
$2.522B
▲ 39.57%
$2.522B
▲ 0.48%
$2.510B
▲ 6.00%
$2.368B
▲ 6.09%
$2.232B
▼ 1.20%
$2.259B
▲ 1.12%
$2.234B
▲ 11.03%
$2.012B
▼ 5.23%
$2.123B
▼ 0.42%
$2.132B
▼ 1.34%
$2.161B
▲ 10.09%
$1.963B
▼ 1.46%
$1.992B
▲ 10.24%
2012
$1.807B
▲ 33.75%
$1.807B
▼ 3.01%
$1.863B
▲ 2.81%
$1.812B
▼ 6.11%
$1.930B
▲ 9.04%
$1.770B
▲ 6.76%
$1.658B
▲ 3.30%
$1.605B
▼ 1.89%
$1.636B
▼ 6.03%
$1.741B
▼ 1.75%
$1.772B
▲ 3.14%
$1.718B
▲ 4.06%
$1.651B
▲ 22.21%
2011
$1.351B
▼ 32.65%
$1.351B
▼ 3.64%
$1.402B
▼ 12.16%
$1.596B
▲ 12.16%
$1.423B
▼ 16.34%
$1.701B
▼ 16.25%
$2.031B
▼ 2.87%
$2.091B
▲ 4.65%
$1.998B
▼ 8.35%
$2.180B
▲ 10.10%
$1.980B
▼ 3.79%
$2.058B
▼ 4.90%
$2.164B
▲ 7.88%
2010
$2.006B
▼ 9.60%
$2.006B
▲ 6.42%
$1.885B
▼ 0.32%
$1.891B
▼ 1.15%
$1.913B
▲ 2.19%
$1.872B
▼ 9.08%
$2.059B
▼ 9.18%
$2.267B
▲ 2.12%
$2.220B
▲ 0.18%
$2.216B
▼ 14.83%
$2.602B
▲ 4.12%
$2.499B
▲ 4.39%
$2.394B
▲ 7.89%
2009
$2.219B
▲ 25.16%
$2.219B
▲ 4.72%
$2.119B
▼ 11.93%
$2.406B
▼ 1.27%
$2.437B
▲ 7.22%
$2.273B
▲ 4.31%
$2.179B
▼ 2.02%
$2.224B
▲ 7.03%
$2.078B
▲ 12.51%
$1.847B
▲ 1.65%
$1.817B
▲ 9.72%
$1.656B
▲ 0.24%
$1.652B
▼ 6.82%
2008
$1.773B
▼ 60.46%
$1.773B
▲ 14.91%
$1.543B
▼ 36.53%
$2.431B
▼ 35.47%
$3.767B
▼ 15.37%
$4.451B
▼ 1.29%
$4.509B
▲ 3.97%
$4.337B
▼ 0.96%
$4.379B
▲ 10.52%
$3.962B
▼ 1.52%
$4.023B
▲ 0.73%
$3.994B
▼ 5.89%
$4.244B
▼ 5.35%
2007
$4.484B
▲ 54.99%
$4.484B
▲ 3.89%
$4.316B
▲ 9.52%
$3.941B
▲ 3.36%
$3.813B
▲ 6.99%
$3.564B
▲ 2.53%
$3.476B
▲ 0.06%
$3.474B
▼ 2.91%
$3.578B
▲ 12.27%
$3.187B
▲ 2.94%
$3.096B
▲ 0.85%
$3.070B
▲ 1.96%
$3.011B
▲ 4.08%
2006
$2.893B
▼ 5.58%
$2.893B
▲ 3.58%
$2.793B
▼ 2.68%
$2.870B
▼ 3.20%
$2.965B
▲ 6.81%
$2.776B
▲ 14.47%
$2.425B
▼ 3.50%
$2.513B
▼ 12.98%
$2.888B
▼ 16.10%
$3.442B
▼ 3.61%
$3.571B
▲ 2.06%
$3.499B
▲ 4.82%
$3.338B
▲ 8.94%
2005
$3.064B
▲ 1.22%
$3.064B
▼ 7.01%
$3.295B
▲ 4.11%
$3.165B
▲ 0.35%
$3.154B
▼ 13.54%
$3.648B
▲ 4.35%
$3.496B
▲ 1.16%
$3.456B
▲ 7.80%
$3.206B
▲ 1.52%
$3.158B
▲ 0.77%
$3.134B
▲ 3.33%
$3.033B
▼ 2.69%
$3.117B
▲ 2.97%
2004
$3.027B
▲ 92.56%
$3.027B
▼ 0.07%
$3.029B
▼ 0.10%
$3.032B
▲ 42.95%
$2.121B
▲ 5.42%
$2.012B
▼ 3.41%
$2.083B
▼ 7.71%
$2.257B
▲ 8.51%
$2.080B
▼ 1.98%
$2.122B
▲ 7.44%
$1.975B
▲ 0.15%
$1.972B
▲ 7.23%
$1.839B
▲ 16.98%
2003
$1.572B
▼ 9.66%
$1.572B
▲ 5.86%
$1.485B
▲ 0.61%
$1.476B
▲ 5.13%
$1.404B
▼ 13.87%
$1.630B
▼ 3.78%
$1.694B
▲ 15.47%
$1.467B
▲ 1.95%
$1.439B
▲ 16.99%
$1.230B
▲ 6.40%
$1.156B
▼ 14.56%
$1.353B
▲ 0.45%
$1.347B
▼ 22.59%
2002
$1.740B
▲ 17.49%
$1.740B
▲ 5.45%
$1.650B
▼ 0.54%
$1.659B
▼ 6.27%
$1.770B
▲ 0.06%
$1.769B
▲ 3.75%
$1.705B
▲ 8.74%
$1.568B
▼ 4.04%
$1.634B
▲ 22.67%
$1.332B
▼ 2.84%
$1.371B
▲ 4.50%
$1.312B
▼ 2.89%
$1.351B
▼ 8.78%
2001
$1.481B
▲ 50.66%
$1.481B
▲ 1.23%
$1.463B
▼ 1.35%
$1.483B
▼ 4.51%
$1.553B
▼ 0.96%
$1.568B
▲ 17.81%
$1.331B
▼ 2.42%
$1.364B
▲ 7.23%
$1.272B
▲ 27.84%
$0.995B
▲ 0.20%
$0.993B
▲ 14.27%
$0.869B
▼ 14.22%
$1.013B
▲ 3.05%
2000
$0.983B
▲ 126.50%
$0.983B
▲ 27.99%
$0.768B
▼ 18.56%
$0.943B
▼ 22.77%
$1.221B
▲ 124.45%
$0.544B
▼ 9.03%
$0.598B
▲ 35.91%
$0.440B
▲ 1.38%
All market cap values reflect closing prices for the period shown.
📊 Charles River Laboratories International Market Cap and Other Industry Peers
Below are selected companies from the Life Sciences Tools & Services sector / subsector:
Data reflect the most recent market capitalization values available.
💡 What Is Market Capitalization and How Do We Calculate It?
For Charles River Laboratories International Inc. (CRL), market capitalization represents the total market value of the company’s publicly traded shares. It helps investors understand Charles River Laboratories International’s size within the health care sector and compare it with other companies in the same industry.
In most cases, market capitalization is calculated by multiplying the current share price by the number of basic shares outstanding. Basic shares represent the actual number of common shares that currently exist, without including potential future shares from employee stock options, RSUs, warrants, or convertible securities. For example, if Charles River Laboratories International had one million basic shares and each traded at $50, its market capitalization would be $50 million.
Formula: Market Cap = Share Price × Shares Outstanding
The value of Charles River Laboratories International’s market capitalization changes throughout the trading day because it mainly depends on the current share price. The number of shares outstanding typically remains stable unless the company issues new shares, buys back its own stock, or grants stock options to employees.
Based on the latest data, Charles River Laboratories International had a market capitalization of $9.500 billion, placing it in the mid-cap category within the health care industry.
Disclaimer: Despite all efforts, there may still be minor inaccuracies present in the data.